Influence of metal cations on plasma trough concentration of mycophenolic acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 6, 2008, Pages 1292-1296

  Naito, Takafumi ^a   Mino, Yasuaki ^a   Otsuka, Atsushi ^b   Ushiyama, Tomomi ^b   Ozono, Seiichiro ^b   Kagawa, Yoshiyuki ^a   Kawakami, Junichi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Calcineurin inhibitor; Drug interaction; Metal cation; Mycophenolic acid

Indexed keywords

ALUMINUM HYDROXIDE; ANTIANEMIC AGENT; CALCINEURIN INHIBITOR; CALCIUM LACTATE; CYCLOSPORIN A; FERROUS FUMARATE; GLUCURONIDE; MAGNESIUM OXIDE; METAL ION; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID 7 O GLUCURONIDE; SODIUM FERROUS CITRATE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CONSTIPATION; DRUG BLOOD LEVEL; FEMALE; GASTRITIS; HUMAN; HYPOCALCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IRON DEFICIENCY ANEMIA; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; GLUCURONIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METALS; MIDDLE AGED; MYCOPHENOLIC ACID; REGRESSION ANALYSIS; TACROLIMUS;

EID: 45749090148     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.1292     Document Type: Article

References (28)

1. Halloran P. F., N. Engl. J. Med., 351, 2715-2729 (2004).
2. Vidal E., Cantarell C., Capdevila L., Monforte V., Roman A., Pou L., Pharmacol. Toxicol., 87, 182-184 (2000).
3. Smak Gregoor P. J., van Gelder T., Hesse C. J., van der Mast B. J., van Besouw N. M., Weimar W., Nephrol. Dial. Transplant., 14, 706-708 (1999).
4. Filler G., Zimmering M., Mai I., Pediatr. Nephrol., 14, 100-104 (2000).
5. Zucker K., Tsaroucha A., Olson L., Esquenazi V., Tzakis A., Miller J., Ther. Drug Monit., 21, 35-43 (1999).
6. Cattaneo D., Perico N., Gaspari F., Gotti E., Remuzzi G., Kidney Int., 62, 1060-1067 (2002).
7. Kobayashi M., Saitoh H., Kobayashi M., Tadano K., Takahashi Y., Hirano T., J. Pharmacol. Exp. Ther., 309, 1029-1035 (2004).
8. Deters M., Kirchner G., Koal T., Resch K., Kaever V., Ther. Drug Monit., 27, 132-138 (2005).
9. Lorenz M., Kletzmayr J., Perschl A., Furrer A., Horl W. H., Sunder-Plassmann G., J. Am. Soc. Nephrol., 13, 794-797 (2002).
10. Morii M., Ueno K., Ogawa A., Kato R., Yoshimura H., Wada K., Hashimoto H., Takada M., Tanaka K., Nakatani T., Shibakawa M., Clin. Pharmacol. Ther., 68, 613-616 (2000).
11. Kato R., Ooi K., Ikura-Mori M., Tsuchishita Y., Hashimoto H., Yoshimura H., Uenishi K., Kawai M., Tanaka K., Ueno K., J. Clin. Pharmacol., 42, 1275-1280 (2002).
12. Mudge D. W., Atcheson B., Taylor P. J., Sturtevant J. M., Hawley C. M., Campbell S. B., Isbel N. M., Nicol D. L., Pillans P. I., Johnson D. W., Transplantation, 77, 206-209 (2004).
13. Lorenz M., Wolzt M., Weigel G., Puttinger H., Horl W. H., Fodinger M., Speiser W., Sunder-Plassmann G., Am. J. Kidney Dis., 43, 1098-1103 (2004).
14. Gelone D. K., Park J. M., Lake K. D., Pharmacotherapy, 27, 1272-1278 (2007).
15. Bullingham R., Shah J., Goldblum R., Schiff M., Br. J. Clin. Pharmacol., 41, 513-516 (1996).
16. Bullingham R., Monroe S., Nicholls A., Hale M., J. Clin. Pharmacol., 36, 315-324 (1996).
17. Cremers S., Schoemaker R., Scholten E., den Hartigh J., Konig-Quartel J., van Kan E., Paul L., de Fijter J., Br. J. Clin. Pharmacol., 60, 249-256 (2005).
18. Mino Y., Naito T., Matsushita T., Kagawa Y., Kawakami J., J. Pharm. Biomed. Anal., 46, 603-608 (2008).
19. Naito T., Shinno K., Maeda T., Kagawa Y., Hashimoto H., Otsuka A., Takayama T., Ushiyama T., Suzuki K., Ozono S., Biol. Pharm. Bull., 29, 275-280 (2006).
20. Lidgate D., Brandl M., Holper M., Abubakari A., Wu X., Drug Dev. Ind. Pharm., 28, 1275-1283 (2002).
21. Badrick A. C., Jones C. E., Transplantation, 84, 799-800 (2007).
22. Ducray P. S., Banken L., Gerber M., Boutouyrie B., Zandt H., Br. J. Clin. Pharmacol., 62, 492-495 (2006).
23. Westley I. S., Brogan L. R., Morris R. G., Evans A. M., Sallustio B. C., Drug Metab. Dispos., 34, 261-266 (2006).
24. Filler G., Ehrich J., Nephrol. Dial. Transplant., 12, 374-375 (1997).
25. Shaw L. M., Kaplan B., Brayman K. L., Clin. Chem., 44, 381-387 (1998).
26. Lu Y. P., Zhu Y. C., Liang M. Z., Nan F., Yu Q., Wang L., Wang J., Li Y. P., Transplant. Proc., 38, 2048-2050 (2006).
27. Kaplan B., Curr. Med. Res. Opin., 22, 2355-2364 (2006).
28. Fernández A., Martins J., Villlafruela J. J., Marcén R., Pascual J., Cano T., Puig C., Gil-Casares B., Muriel A., Burgos F. J., Ortuño J., Transplant. Proc., 39, 2185-2186 (2007).